Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
D.5NUS-CDC-N-3GGGAGCCTTGAATACACCAAAA2245.452868128702F-22824.1US
B.1.81ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
B.1.81NCN-CDC-NCAGACATTTTGCTCTCAAGCTG2245.452897928958R-23140.2China
B.1.81NUS-CDC-N-3GGGAGCCTTGAATACACCAAAA2245.452868128702F-22824.1US
B.1.258.24ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
B.1.258.24NCN-CDC-NCAGACATTTTGCTCTCAAGCTG2245.452897928958R-23140.2China
B.1.258.24NUS-CDC-N-3GGGAGCCTTGAATACACCAAAA2245.452868128702F-22824.1US
B.1.160.11ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
B.1.160.11NCN-CDC-NCAGACATTTTGCTCTCAAGCTG2245.452897928958R-18066.2China
B.1.160.11NUS-CDC-N-3GGGAGCCTTGAATACACCAAAA2245.452868128702F-22824.1US
B.1.160.10ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-3196.01Germany
B.1.160.10NCN-CDC-NCAGACATTTTGCTCTCAAGCTG2245.452897928958R-18066.2China
B.1.160.10NUS-CDC-N-3GGGAGCCTTGAATACACCAAAA2245.452868128702F-22824.1US
B.1.177.71ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-3196.01Germany
B.1.177.71NCN-CDC-NCAGACATTTTGCTCTCAAGCTG2245.452897928958R-23140.2China
B.1.177.71NUS-CDC-N-3GGGAGCCTTGAATACACCAAAA2245.452868128702F-22824.1US
B.1.1.445ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-3196.01Germany
B.1.1.445NCN-CDC-NCAGACATTTTGCTCTCAAGCTG2245.452897928958R-18066.2China
B.1.1.445NUS-CDC-N-3GGGAGCCTTGAATACACCAAAA2245.452868128702F-22824.1US
AY.21 (Delta)ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
AY.21 (Delta)NCN-CDC-NCAGACATTTTGCTCTCAAGCTG2245.452897928958R-23140.2China
AY.21 (Delta)NUS-CDC-N-3GGGAGCCTTGAATACACCAAAA2245.452868128702F-22824.1US
B.1.160.20ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
B.1.160.20NCN-CDC-NCAGACATTTTGCTCTCAAGCTG2245.452897928958R-18066.2China
B.1.160.20NUS-CDC-N-3GGGAGCCTTGAATACACCAAAA2245.452868128702F-22824.1US
B.1.160.19ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
B.1.160.19NCN-CDC-NCAGACATTTTGCTCTCAAGCTG2245.452897928958R-18066.2China
B.1.160.19NUS-CDC-N-3GGGAGCCTTGAATACACCAAAA2245.452868128702F-22824.1US
B.1.160.12ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
B.1.160.12NCN-CDC-NCAGACATTTTGCTCTCAAGCTG2245.452897928958R-18066.2China
B.1.160.12NUS-CDC-N-3GGGAGCCTTGAATACACCAAAA2245.452868128702F-22824.1US
AT.1ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-3196.01Germany
AT.1NCN-CDC-NCAGACATTTTGCTCTCAAGCTG2245.452897928958R-23140.2China
AT.1NUS-CDC-N-3GGGAGCCTTGAATACACCAAAA2245.452868128702F-22824.1US
B.1.619.1ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
B.1.619.1NCN-CDC-NCAGACATTTTGCTCTCAAGCTG2245.452897928958R-23267.5China
B.1.619.1NUS-CDC-N-3GGGAGCCTTGAATACACCAAAA2245.452868128702F-22824.1US
P.1.12.1 (Gamma)ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
P.1.12.1 (Gamma)NCN-CDC-NCAGACATTTTGCTCTCAAGCTG2245.452897928958R-23140.2China
P.1.12.1 (Gamma)NUS-CDC-N-3GGGAGCCTTGAATACACCAAAA2245.452868128702F-22824.1US
B.1.160.22ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
B.1.160.22NCN-CDC-NCAGACATTTTGCTCTCAAGCTG2245.452897928958R-18066.2China
B.1.160.22NUS-CDC-N-3GGGAGCCTTGAATACACCAAAA2245.452868128702F-22824.1US
AZ.2.1ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
AZ.2.1NCN-CDC-NCAGACATTTTGCTCTCAAGCTG2245.452897928958R-19013.6China
AZ.2.1NUS-CDC-N-3GGGAGCCTTGAATACACCAAAA2245.452868128702F-22824.1US
B.1.260ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
B.1.260NCN-CDC-NCAGACATTTTGCTCTCAAGCTG2245.452897928958R-23140.2China
B.1.260NUS-CDC-N-3GGGAGCCTTGAATACACCAAAA2245.452868128702F-22824.1US
B.1.456ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used